Arrowhead Pharmaceuticals Inc Com (NASDAQ:ARWR)

CAPS Rating: 2 out of 5

A development stage nanotechnology company commercializing new technologies in the areas of life sciences, electronics, and energy.

ARWR News and Commentary

Caps

How do you think ARWR will perform against the market?

Add Stock to CAPS Watchlist

All Players

195 Outperform
18 Underperform
 

All-Star Players

37 Outperform
10 Underperform
 

Wall Street

2 Outperform
1 Underperform
 

Top ARWR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Liberty4Freedom (< 20)
Submitted December 23, 2013

An announcement is coming after January 2014.

NetscribeServcs (< 20)
Submitted February 19, 2007

“Arrow - Heading” downward.Arrowhead Research Corporation (Arrowhead) is a development stage nanotechnology company, commercializing technologies in the areas of life sciences, electronics and energy. Arrowhead operates four majority-owned… More

ARWR VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about ARWR.

Recs

0
Member Avatar Quickcard (< 20) Submitted: 10/10/2017 5:07:56 PM : Outperform Start Price: $4.02 ARWR Score: +241.29

Pharma companies with what are doing research with verifiable positive results in treatment for especially intractable medical conditions seem to be on a roll. I don't see this should not continue, especially as DNA/RNA research is reaching new highs at the same time.

Recs

0
Member Avatar motto1628 (44.89) Submitted: 10/4/2015 2:59:52 AM : Outperform Start Price: $5.99 ARWR Score: +94.38

Functional cure for Hep B

Recs

0
Member Avatar sstuart111549 (< 20) Submitted: 9/24/2015 2:13:22 PM : Outperform Start Price: $7.42 ARWR Score: +46.00

hep b cure

Leaderboard

Find the members with the highest scoring picks in ARWR.

Score Leader

Bigsef77

Bigsef77 (70.32) Score: +808.92

Tampering with mailboxes is a federal offense son!

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
mistermiranga 99.53 12/1/2016 Outperform 5Y $1.41 +900.00% +25.13% +874.87 0 Comment
Bigsef77 70.32 4/25/2017 5/9/2018 Outperform 3Y $1.52 +824.40% +15.49% +808.92 0 Comment
KidJones 30.00 4/22/2013 Outperform 5Y $1.78 +689.33% +76.79% +612.54 0 Comment
whoodatstockhot 75.31 7/8/2013 Outperform 5Y $2.02 +595.54% +68.07% +527.47 0 Comment
EvilEmpire 29.91 2/28/2013 Outperform 5Y $2.20 +538.64% +81.30% +457.33 0 Comment
hayrettin 70.95 8/24/2017 Outperform 5Y $2.50 +463.13% +12.62% +450.51 0 Comment
MFBurritoSquat 51.92 12/19/2012 Outperform 3M $2.23 +530.04% +89.24% +440.81 0 Comment
beecha 41.06 9/19/2017 Outperform 5Y $3.35 +319.40% +10.16% +309.24 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Under5 52.08 9/13/2017 Outperform 5Y $3.42 +311.42% +10.17% +301.25 0 Comment
AJL7 < 20 2/3/2016 Outperform 5Y $3.26 +330.98% +43.88% +287.10 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
trackchardan 62.48 11/30/2016 Outperform NS $1.69 +731.36% +24.26% +707.10 0 Comment
TrackJimCramer 85.44 2/26/2015 Underperform 3W $7.74 +81.52% +30.29% -51.24 0 Comment
TrackDeutscheSec 87.47 3/5/2014 Outperform NS $24.99 -43.78% +46.71% -90.49 0 Comment
TrackGlobalCrown < 20 4/24/2007 Outperform NS $61.70 -92.35% -6.19% -86.16 4/17/2012 @ $4.72 0 Comment

Featured Broker Partners


Advertisement